CAH

CAH

USD

Cardinal Health Inc. Common Stock

$195.340+4.910 (2.578%)

即時價格

Healthcare
Medical Distribution
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$190.430

最高

$196.960

最低

$189.980

交易量

1.20M

公司基本面

市值

46.4B

行業

Medical Distribution

國家

United States

交易統計

平均交易量

2.51M

交易所

NYQ

貨幣

USD

52週範圍

最低 $110.63當前 $195.340最高 $197.67

相關新聞

PR Newswire

Cardinal Health Board of Directors Approves Quarterly Dividend

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's...

查看更多
Cardinal Health Board of Directors Approves Quarterly Dividend
Analyst Upgrades

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $210

Mizuho analyst Steven Valiquette maintains Cardinal Health with a Outperform and raises the price target from $170 to $210.

查看更多
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $210
Analyst Upgrades

TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $225

TD Cowen analyst Charles Rhyee maintains Cardinal Health with a Buy and raises the price target from $183 to $225.

查看更多
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $225
PR Newswire

Cardinal Health completes acquisition of Solaris Health

Cardinal Health (NYSE: CAH) announced today that it has completed its acquisition of Solaris Health, the country's leading urology MSO. Solaris...

查看更多
Cardinal Health completes acquisition of Solaris Health
Analyst Upgrades

Citigroup Maintains Neutral on Cardinal Health, Raises Price Target to $190

Citigroup analyst Daniel Grosslight maintains Cardinal Health with a Neutral and raises the price target from $165 to $190.

查看更多
Citigroup Maintains Neutral on Cardinal Health, Raises Price Target to $190
Analyst Upgrades

UBS Maintains Buy on Cardinal Health, Raises Price Target to $220

UBS analyst Kevin Caliendo maintains Cardinal Health with a Buy and raises the price target from $185 to $220.

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $220

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health with a Outperform and raises the price target from $190 to $220.